See what expert industry speakers will be covering, including:
Disrupting the status quo to find the right collaboration partner – focused on internal and external collaboration, featuring an open discussion around new collaboration models to impact patients in more meaningful ways.
Real-world evidence – overcoming barriers to RWE adoption, realizing value and finding the intersections between AI and RWE lie to better treat patients.
Use cases presenting what has been learned by early adopters using AI in drug discovery.
Unlocking the value of data – collecting the right kind of information and determining how ML/AI can be used to optimize it.
AI for clinical development – improving success outcomes, realizing the potential of virtual and hybrid clinical trials, and lowering costs.